Carmell Co. (NASDAQ:CTCX) Sees Significant Growth in Short Interest

Carmell Co. (NASDAQ:CTCX) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 827,600 shares, an increase of 688.2% from the December 15th total of 105,000 shares. Based on an average daily trading volume, of 10,930,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 6.1% of the shares of the company are short sold.

Carmell Price Performance

CTCX traded up $0.06 during trading on Monday, hitting $0.55. 652,582 shares of the company traded hands, compared to its average volume of 47,532,453. The stock’s fifty day moving average is $0.30 and its 200 day moving average is $0.62. Carmell has a one year low of $0.20 and a one year high of $4.00.

Hedge Funds Weigh In On Carmell

An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC bought a new position in shares of Carmell Co. (NASDAQ:CTCX) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned 0.22% of Carmell as of its most recent SEC filing. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Carmell Company Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.